Embody’s advertised GLP-1 prices are strikingly low. The more important question is what patients receive for that price—and what happens after payment.
Embody is a cash-pay telehealth service operated by Modern Metabolic Medicine, Inc. It connects adults with OpenLoop Health clinicians who may prescribe compounded semaglutide or tirzepatide following a medical review. Medication, shipping, clinical oversight and coaching are generally included without a separate membership charge.
Our Embody review found a potentially economical program with useful pharmacy disclosures and continuing support. However, its public policies contain conflicting cancellation deadlines, its lowest prices require longer commitments, and its main medications have not been approved by the FDA.
Key takeaways
- Monthly compounded semaglutide currently costs $79 and tirzepatide costs $129. Lower equivalent rates require multi-month commitments.
- Medication, delivery, clinician review, optional coaching and continuing support are generally included.
- Embody lists four partner pharmacies, but patients should confirm which one will dispense their individual prescription.
- The website says prices remain fixed when dosage increases, although the terms allow final charges to vary depending on the prescribed medication and pharmacy.
- Cancellation instructions conflict: different pages require notice before shipment, 72 hours before billing or five days before the prescription period ends.
- Consumer feedback is mixed, with favorable comments about price and convenience alongside complaints involving fulfillment and customer service.
Embody at a glance
| Category | What we found |
|---|---|
| Care model | Online screening, clinician review and home delivery |
| Main treatments | Compounded semaglutide and tirzepatide injections |
| Monthly prices | $79 and $129 |
| Medication included | Yes, when prescribed |
| Separate membership | None advertised |
| Insurance | Cash-pay; affiliated providers are out of network |
| Clinical network | OpenLoop Health |
| Support | Messaging, appointments and optional coaching |
| State availability | Limited to certain states; no public state list |
| Main limitation | Important inconsistencies between marketing pages and legal terms |
Information reviewed August 5, 2026. Pricing, pharmacy assignments and compounded-medication availability can change.
How the Embody program works
Applicants complete a brief assessment covering medical history, current medication, weight and treatment goals. Passing the preliminary screening does not guarantee treatment. After checkout, an OpenLoop Health clinician reviews the information and decides whether prescribing is appropriate. A brief virtual appointment may be arranged when more information is required.
If approved, the clinician sends a patient-specific prescription to a partner pharmacy. The medication is then prepared and shipped to the address on file. Embody says members can message the care team, arrange appointments and request assistance with dosing or side effects.
People transferring from another provider may be asked to submit proof of their existing prescription. Continuing the same dose remains subject to the new clinician’s judgment.
What medications does Embody offer?
Embody’s current program focuses on:
- Compounded semaglutide: a weekly GLP-1 injection
- Compounded tirzepatide: a weekly dual GIP/GLP-1 injection
These products are not FDA-approved Wegovy or Zepbound, nor are they FDA-approved generic equivalents. The FDA does not review the finished compounded preparation for safety, effectiveness or quality before it is dispensed. Compounded drugs can address a genuine patient-specific need, but the FDA advises using them only when an approved medication cannot meet that need.
Embody says its products are prepared through state-licensed 503A pharmacies. Its website lists Red Rock Pharmacy, HealthWarehouse, Precision Compounding Pharmacy and Triad Rx as partners. The pharmacy used may depend on location, formulation and availability.
Before treatment, ask for the dispensing pharmacy’s name, address and license information, as well as the medication’s ingredients and concentration.
How much does Embody cost?
The current active pricing schedule is:
| Plan | Semaglutide | Tirzepatide |
|---|---|---|
| Monthly | $79/month | $129/month |
| Three months | $76/month | $126/month |
| Six months | $73/month | $123/month |
| 12 months | $69/month | $119/month |
The lowest equivalent rates require commitments totaling approximately $828 for semaglutide or $1,428 for tirzepatide. Embody’s terms say members remain responsible for their current commitment period and generally cannot receive refunds for unused portions.
The advertised price ordinarily includes:
- Medical evaluation and prescription review
- Compounded medication
- Dose changes within the same treatment
- Delivery
- Optional care coaching
- Messaging and clinical follow-up
The website repeatedly promises fixed pricing as dosage increases. Its terms nevertheless say the final card charge may vary according to the medication and fulfillment pharmacy. A written checkout summary should therefore confirm the total commitment, renewal date and circumstances in which the charge can change.
Insurance, laboratories and continuing care
Embody’s affiliated medical groups are out of network with commercial insurance, Medicare and Medicaid. Services, medication and laboratory testing may not be reimbursed. The homepage describes purchases as HSA/FSA approved, but eligibility ultimately depends on the account administrator and expense.
Laboratory testing is mentioned only as applicable, rather than as a standard included service. Patients should ask whether testing is required, which laboratory is used and whether the quoted subscription covers it.
Embody advertises 24/7 messaging, unlimited appointments and optional coaching. Coaching is delivered by nonclinical staff and is not required before medication is prescribed. Consumers should clarify whether overnight messages reach a clinician immediately or enter a queue for later response. (Embody)
Cancellation, refunds and the satisfaction guarantee
Embody’s cancellation language is inconsistent:
- The homepage says cancellation is allowed before the next shipment.
- The refund policy requires at least 72 hours’ notice before billing.
- The terms require cancellation five days before the prescription period ends.
The safest approach is to cancel through the portal at least five days before renewal and retain written confirmation.
A patient found medically ineligible should receive a refund for medication that has not been dispensed. Once medication has been ordered, compounded, processed or shipped, it is generally nonrefundable.
Embody also advertises a 100% satisfaction refund when a member follows the program but does not make “meaningful progress” within six months. Its formal refund policy does not clearly define meaningful progress or list the guarantee’s documentation and adherence requirements. Obtain those conditions in writing before relying on the promise.
Company reputation and transparency
Embody’s operator began business in December 2025, making its long-term record relatively limited. Its Trustpilot profile showed a 3.8 rating from 4,694 reviews at the time of research. Positive themes included price and convenient enrollment; recurring criticisms involved delays, communication and order fulfillment. The profile includes invited reviews and reviews merged from another profile, so the headline score should not be treated as independent clinical evidence.
The Better Business Bureau gave Modern Metabolic Medicine an F rating based on 16 unanswered complaints. BBB also notes that complaint counts should be considered alongside company size and that it does not independently verify every consumer allegation.
Another transparency concern is Embody’s own disclosure that some website material may be generated or enhanced using artificial intelligence and may not be accurate or complete. Its weight-loss claims are based on self-reported patient data, not clinical trials of Embody’s compounded preparations.
Safety and eligibility considerations
Common adverse effects associated with approved semaglutide and tirzepatide products include nausea, vomiting, diarrhea, constipation and abdominal discomfort. Serious label warnings include pancreatitis, gallbladder disease, dehydration-related kidney injury, severe gastrointestinal reactions and hypersensitivity.
Approved products carry boxed warnings regarding thyroid C-cell tumors observed in animals and are contraindicated for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Pregnancy, diabetes medication and significant digestive disease also require careful clinical review.
Compounded vials introduce an additional dosing concern. The FDA has received reports of patients administering substantially more semaglutide than intended because of differences between milligrams, milliliters and syringe “units.” Instructions should specify the prescribed dose, vial concentration and exact syringe marking.
Who may find Embody worth considering?
Embody may appeal to adults who:
- Expect to pay cash
- Accept the limitations of compounded medication
- Want treatment, shipping and support under one price
- Prefer a low monthly cost without a separate membership
- Receive clear answers about their pharmacy and prescription
It may not suit people who want only an FDA-approved medication, need insurance authorization, require established in-person obesity care or are uncomfortable with multi-month commitments and evolving compounding rules.
Questions to ask before enrolling
- Why is compounded treatment appropriate for my individual needs?
- Which pharmacy will fill my prescription?
- What ingredients and concentration will I receive?
- Can my price change despite the flat-rate advertisement?
- Are laboratory tests required or included?
- Who answers messages outside normal hours?
- What exact date must I cancel?
- What qualifies as “meaningful progress” under the guarantee?
Final assessment
Embody combines unusually low prices with a more substantial support model than many medication-only websites. Its named clinical network, published pharmacy list and dose-independent pricing are meaningful positives.
The fine print prevents an unqualified recommendation. Cancellation deadlines conflict, longer commitments have limited refund rights, consumer feedback is mixed and the main products are compounded during a period of increasing FDA scrutiny.
Embody may be worth considering for a carefully screened cash-pay patient who understands those tradeoffs. Before enrolling, obtain written confirmation of the total charge, formulation, dispensing pharmacy, cancellation deadline and clinical reason for using a compounded product.
Frequently asked questions
Is Embody legitimate?
Embody is operated by Modern Metabolic Medicine, Inc. and connects patients with OpenLoop Health clinicians and named pharmacies. That makes it an identifiable telehealth business, but it does not mean Embody or its compounded medications are FDA approved.
Does Embody include medication in the price?
Yes, the advertised subscription generally includes medication when prescribed, clinical review, shipping and support. The final price can still vary if the medication or treatment plan changes.
Does Embody accept insurance?
The program is primarily cash-pay. Its affiliated medical providers are out of network, and Embody does not advertise prior-authorization assistance.
Will the price increase at higher doses?
Embody says the price remains unchanged when the dose increases within the same medication and plan. Switching medications or plans may change the cost, and its terms reserve some price variability.
Can I cancel Embody at any time?
You can stop future renewals, but the published notice periods conflict. Submit cancellation at least five days before the next prescription period and obtain written confirmation.
Is Embody’s medication FDA approved?
No. Its principal semaglutide and tirzepatide products are compounded preparations and have not been evaluated or approved by the FDA.
